Authors
Latest:
ABCs of Avoiding Microvascular Comorbidities of DiabetesDr. Santamarina is an assistant professor of pharmacy practice at Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy, West Palm Beach, Fla.
Latest:
Ensuring Health Equity in Vaccination Access: How Pharmacies Can Work With Community OrganizationsCommunity pharmacies and organizations can collaborate to tailor strategies and interventions and address the challenges and specific needs of the community.
Latest:
Use of Multiple Sclerosis Disease-Modifying Therapies During COVID-19 PandemicIn the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.
Latest:
Comparing Direct Medical Costs of OnabotulinumtoxinA With Other Common Overactive Bladder InterventionsThis cost analysis demonstrated that onabotulinumtoxinA is one of the least-costly treatment options for inadequately managed overactive bladder syndrome.
Latest:
Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWDThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Cannabidiol Gets Thumbs Up from Federal AgenciesThe FDA approved cannabidiol (CBD) last year for the treatment of seizures associated with Lennox-Gastaut and Dravet syndromes in patients aged 2 years and older. As pharmacists, we will likely be called upon as experts in CBD therapeutics.
Latest:
Through Thick and Thin: Using Anticlotting DrugsHelping patients understand their regimen can boost adherence.
Latest:
Direct and Indirect Cost Burden of Chronic Hepatitis CAn estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.
Latest:
Examining Part D Beneficiaries' Medication Use in the Doughnut HoleThe authors found that the Part D doughnut hole significantly reduced the use of medications for treating potentially disabling and life-threatening conditions, but increased out-of-pocket costs for Medicare beneficiaries.
Latest:
Consider Transdisciplinary Approach to Pain in Patients with CancerManaging cancer pain is a challenge for patients and providers alike.
Latest:
Challenges, Opportunities Mark Health Care Landscape in 2022Burnout, drug and technician shortages, home care, remote work, and telehealth continue to trend
Latest:
Poison Control Centers Offer Unique Opportunities for PharmacistsMore than $45 million in health care expenditures is prevented, and that money saved, annually by Arizona’s 2 poison control centers. But what do they do?
Latest:
A Predictive Modeling Primer for Specialty PharmacyAs the industry focuses more on value-based care, predictive modeling allows pharmacies to shift their services from a one-size-fits-all approach to a personalized, high-touch strategy.
Latest:
The Implications of Antibiotic Overuse Warrant Attention to GuidelinesUp to half of antibiotics prescribed in the United States may be unnecessary, leading to avoidable adverse events and development of antibiotic resistance and attendant costs.
Latest:
Current Tech Hurdles in Specialty Pharmacy Lead to a Decrease in Effective CareLost within the fast-paced specialty pharmacy environment are updates to pharmacy software systems that can accommodate the ever-growing needs of patients.
Latest:
A Pharmacist’s Guide to Diabetic KetoacidosisDiabetic ketoacidosis poses serious risks for patients with diabetes, requiring urgent treatment to prevent life-threatening complications and ensure recovery.
Latest:
Any Willing Provider Legislation May Squeeze Independent Practice PharmaciesIndependents grapple with increasingly aggressive policies among payers, pharmacy benefit managers, and pharma companies.
Latest:
Predictive Analytics: A Case Study in Machine-Learning and Claims DatabasesA state-of-the-art predictive analysis tool that finds patients with rare diseases in a complex database could be valuable to stakeholders, who would achieve savings by helping physicians prescribe the appropriate treatment sooner.
